Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

362 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Black Adolescent Females' Perceptions of PrEP for HIV Risk Reduction.
Budge M, Opara I, Weser VU, Sands BE, Hieftje KD. Budge M, et al. Among authors: sands be. J Int Assoc Provid AIDS Care. 2023 Jan-Dec;22:23259582231206934. doi: 10.1177/23259582231206934. J Int Assoc Provid AIDS Care. 2023. PMID: 37853731 Free PMC article.
Tamuzimod in patients with moderately-to-severely active ulcerative colitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 induction trial.
Sands BE, Panaccione R, D'Haens G, Schreiber S, Jairath V, DuVall A, Kierkus J, Walczak M, Naik S, Gilder K, Lindstrom B, Ogilvie K, Sandborn WJ, Vermeire S, Rubin DT, Peyrin-Biroulet L, Danese S. Sands BE, et al. Lancet Gastroenterol Hepatol. 2025 Jan 7:S2468-1253(24)00386-8. doi: 10.1016/S2468-1253(24)00386-8. Online ahead of print. Lancet Gastroenterol Hepatol. 2025. PMID: 39793589
Reply to Lewis.
Hanauer SB, Sands BE, Colombel JF. Hanauer SB, et al. Among authors: sands be. Gastroenterology. 2025 Jan 4:S0016-5085(25)00003-4. doi: 10.1053/j.gastro.2024.12.018. Online ahead of print. Gastroenterology. 2025. PMID: 39761930 No abstract available.
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Among authors: sands be. Lancet. 2025 Jan 4;405(10472):33-49. doi: 10.1016/S0140-6736(24)01927-5. Epub 2024 Dec 17. Lancet. 2025. PMID: 39706209 Clinical Trial.
Acute Severe Ulcerative Colitis: An International Delphi Consensus on Clinical Trial Design and Endpoints.
Honap S, Jairath V, Sands BE, Dulai PS, Higgins PDR, De Cruz P, Gutiérrez A, Kotze PG, Ye BD, Kobayashi T, Gearry RB, Olivera PA, Amiot A, Mosli MH, Al Awadhi S, Halfvarson J, Patel KV, Sebastian S, Danese S, Peyrin-Biroulet L. Honap S, et al. Among authors: sands be. Clin Gastroenterol Hepatol. 2024 Dec 15:S1542-3565(24)01082-6. doi: 10.1016/j.cgh.2024.10.029. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 39681225 Free article.
362 results